Classification by ATC code (Anatomical Therapeutic Chemical)

A Alimentary tract and metabolism

B Blood and blood forming organs

C Cardiovascular system

D Dermatologicals

G Genito urinary system and sex hormones

H Systemic hormonal preparations, excl. sex hormones and insulins

J Antiinfectives for systemic use

L Antineoplastic and immunomodulating agents

L01 Antineoplastic agents

L01A Alkylating agents

L01B Antimetabolites

L01C Plant alkaloids and other natural products

L01D Cytotoxic antibiotics and related substances

L01E Protein kinase inhibitors

L01X Other antineoplastic agents

L01XA Platinum compounds

L01XB Methylhydrazines

L01XC Monoclonal antibodies

L01XC cemiplimabum

L01XC02 rituximabum

L01XC03 trastuzumabum

L01XC04 alemtuzumabum

L01XC05 gemtuzumab ozogamicin

L01XC06 cetuximabum

L01XC07 bevacizumabum

L01XC08 panitumumabum

L01XC09 catumaxomabum

L01XC10 ofatumumab

L01XC11 ipilimumabum

L01XC12 brentuximabum vedotin

L01XC13 pertuzumabum

L01XC14 trastuzumabum emtansinum

L01XC15 obinutuzumabum

L01XC16 dinutuximab beta

L01XC17 nivolumabum

L01XC18 pembrolizumabum

L01XC19 blinatumomabum

L01XC21 ramucirumabum

L01XC24 daratumumabum

L01XC25 mogamulizumab

L01XC26 inotuzumab ozogamicin

L01XC27 olaratumab

L01XC28 durvalumabum

L01XC31 avelumabum

L01XC32 atezolizumab

L01XC37 polatuzumab vedotin

L01XC38 isatuximabum

L01XC41 trastuzumabum deruxtecanum

L01XD Sensitizers used in photodynamic/radiation therapy

L01XF Retinoids for cancer treatment

L01XG Proteasome inhibitors

L01XH Histone deacetylase (hdac) inhibitors

L01XJ Hedgehog pathway inhibitors

L01XK Poly (adp-ribose) polymerase (parp) inhibitors

L01XX Other antineoplastic agents

L01XY Combinations of antineoplastic agents

L02 Endocrine therapy

L03 Immunostimulants

L04 Immunosuppressants

M Musculo-skeletal system

N Nervous system

P Antiparasitic products, insecticides and repellents

R Respiratory system

S Sensory organs

V Various